References
- Lotz BP, Engel AG, Nishio H, Stevens JC, Litchy WJ. Inclusion body myositis: observations on 40 patients. Brain 1989;112: 727–47.
- Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25:240–7.
- Askanas V, Engel WK. New advances in inclusion body myositis. Curr Opin Ftheumatol 1993;5:732–41.
- Sekul EA, Dalakas MC. Inclusion body myositis: new concepts. Semin Neurol 1993;13:256–63.
- Vogel H. Inclusion body myositis. A review. Adv Anatom Pathol 1998;5:164–9.
- Asakanas V, Engel WK. Sporadic inclusion body myositis and its similarities to an Alzheimer's disease brain. Scand J Ftheumatol 1998;27:389–405.
- Hilton-Jones D. Inflammatory muscle diseases. Curr Opin Neurol 2001;14:591–6.
- Askanas V, Engel WK. Inclusion body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer's disease. J Neuropathol Exp Neurol 2001;60:1–14.
- Engel AG, Arahata K. Monoclonal antibody analysis of mono-nuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209–15.
- Koffman BM, Rugiero M, Dalakas MC. Immune-mediated condi-tions and antibodies associated with sporadic inclusion body myo-sitis. Muscle Nerve 1998;21:115–7.
- Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH. The treatment of inclusion body myositis: a retrospective review and a random-ized, prospective trial of immunosuppressive therapy. Medicine 1993;72:225–35.
- Yamanishi Y, Maeda H, Katayama S, Ishioka S, Yamakido M. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation. J Ftheumatol 1996;23:1991–4.
- Soveidon SA, Dalaks ML. Treatment of inclusion body myositis with high-dose intravenous immunoglobulin. Neurology 1993;43: 876–9.